AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9430568 — intervention group
Group type: COMPARATOR
Intervention: Saline solution 20 ml (Control Group)
Number of subjects: 142
Study 8512099 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular dexmedetomidine (2.5 micrograms/kg) administered 60 min before induction (DEXPLA group, n = 64)
Number of subjects: 192
Study 8512099 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular dexmedetomidine (2.5 micrograms/kg) and intravenous fentanyl (1.5 micrograms/kg) (DEXFENT group, n = 64)
Number of subjects: 192
Study 8512099 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular midazolam (0.08 mg/kg) and intravenous fentanyl (1.5 micrograms/kg) (MIDFENT group, n = 64)
Number of subjects: 192
Study 8512099 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dexmedetomidine)
Number of subjects: 192
Study 8512099 — intervention group
Group type: EXPERIMENTAL
Intervention: DEXPLA and DEXFENT groups (dexmedetomidine patients)
Number of subjects: 192
Study 3582167 — intervention group
Group type: EXPERIMENTAL
Intervention: DIS
Number of subjects: 0
Study 3582167 — intervention group
Group type: COMPARATOR
Intervention: SADS-L
Number of subjects: 0
Study 3582167 — intervention group
Group type: EXPERIMENTAL
Intervention: DIS and SADS-L
Number of subjects: 0
Study 29374672 — intervention group
Group type: EXPERIMENTAL
Intervention: rfMDA (presumptive treatment with artemether-lumefantrine)
Number of subjects: 56
Study 29374672 — intervention group
Group type: EXPERIMENTAL
Intervention: RACD (rapid diagnostic testing and treatment using artemether-lumefantrine)
Number of subjects: 56
Study 29374672 — intervention group
Group type: EXPERIMENTAL
Intervention: RAVC (IRS with Acellic 300CS)
Number of subjects: 56
Study 29374672 — intervention group
Group type: EXPERIMENTAL
Intervention: rfMDA+RAVC
Number of subjects: 56
Study 29374672 — intervention group
Group type: EXPERIMENTAL
Intervention: RACD+RAVC
Number of subjects: 56
Study 29374672 — intervention group
Group type: COMPARATOR
Intervention: No RAVC
Number of subjects: 56
Study 26419766 — intervention group
Group type: EXPERIMENTAL
Intervention: Theatre-based intervention
Number of subjects: 30
Study 25232074 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary tendon repair
Number of subjects: 103
Study 25232074 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 103
Study 22781525 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance for ilioinguinal or iliohypogastric nerve block with 0.8% lidocaine and 0.25% levobupivacaine at 0.2 ml/kg (Group U)
Number of subjects: 100
Study 22781525 — intervention group
Group type: COMPARATOR
Intervention: Traditional method of anatomical localization with 0.3 ml/kg of the same local anesthetic (Group T)
Number of subjects: 100
Study 22781525 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance (Group U)
Number of subjects: 100
Study 22781525 — intervention group
Group type: COMPARATOR
Intervention: Traditional method (Group T)
Number of subjects: 100
Study 20064249 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac sodium 1% gel (2 g applied to each hand 4 times daily for 8 weeks)
Number of subjects: 783
Study 20064249 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel (vehicle)
Number of subjects: 783
Study 18669967 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprex (pre‐operative injections of epoetin)
Number of subjects: 100
Study 18669967 — intervention group
Group type: COMPARATOR
Intervention: Bellovac (post‐operative retransfusion of shed blood)
Number of subjects: 100
Study 18669967 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprex in total hip replacement
Number of subjects: 100
Study 18669967 — intervention group
Group type: COMPARATOR
Intervention: Bellovac in total hip replacement
Number of subjects: 100
Study 18669967 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprex in total knee replacement
Number of subjects: 100
Study 18669967 — intervention group
Group type: COMPARATOR
Intervention: Bellovac in total knee replacement
Number of subjects: 100
Study 15753747 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline dextran (HSD) 250 mL
Number of subjects: 28
Study 15753747 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluid regimen with hydroxyethyl starch in normal saline solution (H-NS) 250 mL
Number of subjects: 28
Study 12704010 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet intervention (Web site plus 12 weekly e‐mail tip sheets)
Number of subjects: 65
Study 12704010 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 65
Study 12670369 — intervention group
Group type: EXPERIMENTAL
Intervention: IGIV-C, 10% (Gamunex, 10%)
Number of subjects: 38
Study 12670369 — intervention group
Group type: EXPERIMENTAL
Intervention: IGIV-C, 5%
Number of subjects: 38
Study 12670369 — intervention group
Group type: COMPARATOR
Intervention: IGIV-SD, 10% (Gamimune N, 10%)
Number of subjects: 38
Study 12670369 — intervention group
Group type: EXPERIMENTAL
Intervention: IGIV-C, 10%
Number of subjects: 38
Study 9814858 — intervention group
Group type: EXPERIMENTAL
Intervention: Protease inhibitors
Number of subjects: 67
Study 9814858 — intervention group
Group type: COMPARATOR
Intervention: Therapy-naive patients
Number of subjects: 67
Study 9814858 — intervention group
Group type: COMPARATOR
Intervention: HIV-negative control subjects
Number of subjects: 67
Study 7735716 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinic acid
Number of subjects: 0
Study 7735716 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogens
Number of subjects: 0
Study 7735716 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary and pharmacologic agents
Number of subjects: 0
Study 2663975 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 198
Study 2663975 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 198
Study 2663975 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 198
Study 62998 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapsone 5 mg daily
Number of subjects: 68
Study 62998 — intervention group
Group type: COMPARATOR
Intervention: Dapsone 50 mg daily
Number of subjects: 68
Study 28816833 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (25 mg/kg before and after surgery)
Number of subjects: 40
Study 28816833 — intervention group
Group type: COMPARATOR
Intervention: Control (no erythromycin)
Number of subjects: 40
Study 25615892 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice rehabilitation
Number of subjects: 74
Study 25615892 — intervention group
Group type: COMPARATOR
Intervention: Control group (no voice rehabilitation)
Number of subjects: 74
Study 23500267 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 52
Study 23500267 — intervention group
Group type: COMPARATOR
Intervention: Rate control
Number of subjects: 52
Study 21803341 — intervention group
Group type: EXPERIMENTAL
Intervention: Using the mirror box to see the mirror reflection of the non-dominant hand during fatigue-inducing tasks
Number of subjects: 8
Study 21803341 — intervention group
Group type: COMPARATOR
Intervention: Without using the mirror box during fatigue-inducing tasks
Number of subjects: 8
Study 19780000 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiocolchicoside ointment applied onto the trigger points
Number of subjects: 65
Study 19780000 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg thiocolchicoside intramuscular injection to the trigger points
Number of subjects: 65
Study 19780000 — intervention group
Group type: EXPERIMENTAL
Intervention: Both thiocolchicoside ointment and intramuscular injection
Number of subjects: 65
Study 16442479 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom Monitor (intervention group, n = 69)
Number of subjects: 146
Study 16442479 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 77)
Number of subjects: 146
Study 15298946 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum lutein
Number of subjects: 302
Study 15298946 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum zeaxanthin
Number of subjects: 302
Study 15298946 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum beta-cryptoxanthin
Number of subjects: 302
Study 15298946 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum levels of alpha-carotene, beta-carotene, lycopene, and alpha-tocopherol
Number of subjects: 302
Study 11735185 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (150 mg) and below-knee compression stockings (Class 1 profile)
Number of subjects: 39
Study 11735185 — intervention group
Group type: COMPARATOR
Intervention: Control group (no aspirin or stockings)
Number of subjects: 39
Study 9032211 — intervention group
Group type: EXPERIMENTAL
Intervention: PGHS‐1 immunoreactivity
Number of subjects: 41
Study 9032211 — intervention group
Group type: EXPERIMENTAL
Intervention: PGHS‐2 immunoreactivity
Number of subjects: 41
Study 9032211 — intervention group
Group type: COMPARATOR
Intervention: Comparison between patient populations
Number of subjects: 41
Study 9032211 — intervention group
Group type: COMPARATOR
Intervention: Correlation with clinical parameters
Number of subjects: 41
Study 8315162 — intervention group
Group type: EXPERIMENTAL
Intervention: SHAPEDOWN program (family‐based, multidisciplinary, behavior‐modification program)
Number of subjects: 20
Study 8315162 — intervention group
Group type: EXPERIMENTAL
Intervention: SHAPEDOWN program
Number of subjects: 20
Study 8315162 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (standard nutrition care for subjects with IDDM)
Number of subjects: 20
Study 8315162 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 20
Study 8315162 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups
Number of subjects: 20
Study 8315162 — intervention group
Group type: EXPERIMENTAL
Intervention: SHAPEDOWN program and Standard treatment
Number of subjects: 20
Study 3830242 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine 10 mg b.d.
Number of subjects: 8
Study 3830242 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg b.d.
Number of subjects: 8
Study 3830242 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of felodipine and metoprolol
Number of subjects: 8
Study 31233893 — intervention group
Group type: EXPERIMENTAL
Intervention: Directed standing posture
Number of subjects: 60
Study 31233893 — intervention group
Group type: COMPARATOR
Intervention: Natural, relaxed standing posture
Number of subjects: 60
Study 28983060 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone during induction
Number of subjects: 319
Study 28983060 — intervention group
Group type: COMPARATOR
Intervention: Prednisone during induction
Number of subjects: 319
Study 25925729 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical metronidazole treatment
Number of subjects: 47
Study 25925729 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (Control)
Number of subjects: 47
Study 23262116 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based attention training (AT) using a modified dot probe paradigm
Number of subjects: 56
Study 23262116 — intervention group
Group type: COMPARATOR
Intervention: Control condition without attention modification
Number of subjects: 56
Study 22057073 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonazepam (5 mg to 10 mg)
Number of subjects: 23
Study 22057073 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem (1 mg)
Number of subjects: 23
Study 19439813 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 0
Study 19439813 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacidofil
Number of subjects: 0
Study 19439813 — intervention group
Group type: COMPARATOR
Intervention: Candida infection
Number of subjects: 0
Study 17881967 — intervention group
Group type: EXPERIMENTAL
Intervention: Microendoscopic discectomy (MED)
Number of subjects: 40
Study 17881967 — intervention group
Group type: COMPARATOR
Intervention: Open discectomy (OD)
Number of subjects: 40
Study 15501757 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D7 form of MSP2
Number of subjects: 120
Study 11915778 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (CD; 9-10 g carbohydrate/kg lean body mass)
Number of subjects: 6
Study 11915778 — intervention group
Group type: COMPARATOR
Intervention: Habitual diet (HD; 6-7 g carbohydrate/kg lean body mass)
Number of subjects: 6
Study 9931793 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent subglottic lavage (SL)
Number of subjects: 100
Study 8056728 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine (mean sixth week daily dose 370 mg)
Number of subjects: 11
Study 8056728 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol (systematic 6-week trial)
Number of subjects: 11
Study 3051871 — intervention group
Group type: EXPERIMENTAL
Intervention: Multispatula
Number of subjects: 158
Study 3051871 — intervention group
Group type: COMPARATOR
Intervention: Ayres Spatula
Number of subjects: 158
Study 31809216 — intervention group
Group type: COMPARATOR
Intervention: AR19 20 mg
Number of subjects: 96
Study 31809216 — intervention group
Group type: EXPERIMENTAL
Intervention: AR19 5 mg
Number of subjects: 96
Study 31809216 — intervention group
Group type: EXPERIMENTAL
Intervention: AR19 20 mg (intact capsule with meal)
Number of subjects: 96
Study 31809216 — intervention group
Group type: EXPERIMENTAL
Intervention: AR19 20 mg (fasted)
Number of subjects: 96
Study 31809216 — intervention group
Group type: EXPERIMENTAL
Intervention: AR19 30 mg
Number of subjects: 96
Study 30475851 — intervention group
Group type: EXPERIMENTAL
Intervention: Cash transfers (CTs) provided to adolescent girls and young women (AGYW)
Number of subjects: 32
Study 28691360 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% lidocaine spray applied to the ectocervix
Number of subjects: 200
Study 28691360 — intervention group
Group type: COMPARATOR
Intervention: No anesthesia (control group)
Number of subjects: 200
Study 25074639 — intervention group
Group type: EXPERIMENTAL
Intervention: tolcapone
Number of subjects: 66
Study 25074639 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 66
Study 23474344 — intervention group
Group type: EXPERIMENTAL
Intervention: Survivorship Care Plans (SCPs) provided during follow-up visits by physicians (n=64).
Number of subjects: 121
Study 23474344 — intervention group
Group type: COMPARATOR
Intervention: No Survivorship Care Plans (no-SCP condition, n=57).
Number of subjects: 121
Study 21427151 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-minute mental practice
Number of subjects: 29
Study 21427151 — intervention group
Group type: EXPERIMENTAL
Intervention: 40-minute mental practice
Number of subjects: 29
Study 21427151 — intervention group
Group type: EXPERIMENTAL
Intervention: 60-minute mental practice
Number of subjects: 29
Study 21427151 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental practice (all durations)
Number of subjects: 29
Study 21427151 — intervention group
Group type: COMPARATOR
Intervention: Control group (sham intervention)
Number of subjects: 29
Study 18799992 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance training program (4 weeks, supervised, emphasizing dynamic stabilization in single-limb stance)
Number of subjects: 31
Study 16562643 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofibrat 100 mg
Number of subjects: 40
Study 16562643 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 12676060 — intervention group
Group type: EXPERIMENTAL
Intervention: High-functioning individuals with autism
Number of subjects: 24
Study 12676060 — intervention group
Group type: COMPARATOR
Intervention: Normally developing individuals
Number of subjects: 24
Study 10932485 — intervention group
Group type: EXPERIMENTAL
Intervention: THAI version of Aachen aphasia test (THAI-AAT)
Number of subjects: 125
Study 8826768 — intervention group
Group type: EXPERIMENTAL
Intervention: MediHeat adult heating pad (MH-AHP)
Number of subjects: 77
Study 1575555 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 14
Study 1575555 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 14
Study 4059666 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate (BDP) 100 micrograms qds
Number of subjects: 100
Study 4059666 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 31092191 — intervention group
Group type: EXPERIMENTAL
Intervention: Video laryngoscope
Number of subjects: 360
Study 31092191 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscope
Number of subjects: 360
Study 28847207 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary health assessment (n = 83)
Number of subjects: 244
Study 28847207 — intervention group
Group type: COMPARATOR
Intervention: Usual case management (Control group, n = 99)
Number of subjects: 244
Study 26995776 — intervention group
Group type: EXPERIMENTAL
Intervention: OKCKE resistance training at high loads (20 sets of 2RM)
Number of subjects: 26
Study 26995776 — intervention group
Group type: COMPARATOR
Intervention: OKCKE resistance training at low loads (2 sets of 20RM)
Number of subjects: 26
Study 26995776 — intervention group
Group type: COMPARATOR
Intervention: Isokinetic OKCKE resistance training at 2 sets of 20RM
Number of subjects: 26
Study 25039590 — intervention group
Group type: EXPERIMENTAL
Intervention: 100-μs interphase interval (IPI) with one electrode over the common peroneal nerve
Number of subjects: 12
Study 25039590 — intervention group
Group type: EXPERIMENTAL
Intervention: IPI greater than 100μs with one electrode over the common peroneal nerve
Number of subjects: 12
Study 25039590 — intervention group
Group type: EXPERIMENTAL
Intervention: Any IPI with both electrodes over the dorsiflexor muscles
Number of subjects: 12
Study 22166561 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy (peginterferon alfa-2a 180 µg/week + ribavirin 1,000/1,200 mg/day + amantadine 200 mg/day)
Number of subjects: 92
Study 22166561 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (peginterferon alfa-2a 40KD + ribavirin)
Number of subjects: 92
Study 20969664 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid filler injections
Number of subjects: 22
Study 17377646 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical industry sponsorship
Number of subjects: 229
Study 17377646 — intervention group
Group type: COMPARATOR
Intervention: University sponsorship
Number of subjects: 229
Study 15073397 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 630
Study 15073397 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 630
Study 11219760 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting (static posture)
Number of subjects: 8
Study 11219760 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting (dynamic multiple posture approach)
Number of subjects: 8
Study 11219760 — intervention group
Group type: COMPARATOR
Intervention: Standing
Number of subjects: 8
Study 9041968 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapleural streptokinase (SK), 250,000 U in saline solution, mean duration 5.3 days
Number of subjects: 52
Study 9041968 — intervention group
Group type: COMPARATOR
Intervention: Closed chest tube drainage (Drain) only
Number of subjects: 52
Study 9041968 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapleural streptokinase (SK)
Number of subjects: 52
Study 7970934 — intervention group
Group type: EXPERIMENTAL
Intervention: Macrobioitic diet infants
Number of subjects: 41
Study 3296288 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (30-80 mg)
Number of subjects: 61
Study 3296288 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (120-360 mg)
Number of subjects: 61
Study 3296288 — intervention group
Group type: EXPERIMENTAL
Intervention: Phendilin (150-300 mg)
Number of subjects: 61
Study 29870868 — intervention group
Group type: EXPERIMENTAL
Intervention: Point‐of‐Care (POC)
Number of subjects: 226
Study 29870868 — intervention group
Group type: COMPARATOR
Intervention: POC plus Population Management (POC + PM)
Number of subjects: 226
Study 27260323 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month pelvic floor muscle training (PFMT) program delivered via the Internet or a brochure
Number of subjects: 169
Study 27260323 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month pelvic floor muscle training (PFMT) program
Number of subjects: 169
Study 27260323 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular PFMT at 1 year
Number of subjects: 169
Study 27260323 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing age
Number of subjects: 169
Study 24721970 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolomic profiling using high‐performance liquid chromatography‐quadrupole time‐of‐flight mass spectrometry (HPLC‐QTOFMS)
Number of subjects: 138
Study 24721970 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolomic profiling
Number of subjects: 138
Study 23455663 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensorimotor training (2 sessions per week, 30-50 min each session)
Number of subjects: 102
Study 23455663 — intervention group
Group type: COMPARATOR
Intervention: Control group (clinical drug treatment with Methotrexate, Leflunomide and/or Prednisone)
Number of subjects: 102
Study 20520603 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of ephedra dry extract
Number of subjects: 20
Study 20520603 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g of ephedra dry extract
Number of subjects: 20
Study 20520603 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 18799032 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy (RT+BP, RT+TP, RT+FP)
Number of subjects: 285
Study 18799032 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 285
Study 18799032 — intervention group
Group type: EXPERIMENTAL
Intervention: RT+BP, RT+TP, RT+FP
Number of subjects: 285
Study 16651305 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichloroacetate (DCA) at a dose of 12.5 mg/kg every 12 hours for 6 months
Number of subjects: 43
Study 16651305 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 43
Study 12792354 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone (40 mg once daily for 14 days)
Number of subjects: 138
Study 12792354 — intervention group
Group type: COMPARATOR
Intervention: Nevirapine alone
Number of subjects: 138
Study 12792354 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment-naive patients
Number of subjects: 138
Study 10981801 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine hydrochloride
Number of subjects: 12